Ardelyx | ARDX - Ebitda


Ardelyx reported $5.57M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Amgen USD 5.14B 775M Dec/2025
Ardelyx USD 5.57M 17.44M Sep/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Curis USD -12.3M 231K Sep/2023
Sanofi EUR 5.66B 3.77B Sep/2025
TG Therapeutics USD 32.69M 5M Sep/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024